Celularity Inc

CELU Nasdaq SEC CIK 1752828
Follow Celularity Weekly email: filings, results

Financials

Reported figures only · latest: Q2 2026 USD · US GAAP
Revenue, last quarter $5.4M −5.3% vs same quarter last year
Net income $706K +102.9% vs same quarter last year
EPS, diluted $0.02 +102% vs same quarter last year
Operating cash flow −$1.1M −10.9% vs same quarter last year
Revenue by quarter
$9.3M
$18.1M
$11.4M
$5.7M
$5.3M
$4.1M
$3.8M
$5.4M
Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−$300M−$200M−$100M$0$100MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$26.6M−$91.7M
FY24$54.2M−$57.9M
FY23$22.8M−$196.3M
FY22$18M$14.2M
FY21$21.3M−$100.1M
FY20$14.3M−$208.2M
FY19-$5.9M
FY18--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−1500%−1000%−500%0%500%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2524.4%−230.9%−345.4%
FY2472.4%−70.7%−106.8%
FY2329.7%−844.4%−862%
FY22−9.4%−142.4%79%
FY2154.8%−511.2%−469.3%
FY2065.5%−1064%−1458.4%
FY19---
FY18---
Free cash flowOperating cash flow minus capital expenditure
−$150M−$100M−$50M$0FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25-
FY24−$6.6M
FY23−$39.7M
FY22−$143.1M
FY21−$116.3M
FY20−$91M
FY19-
FY18-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Celularity
  • Healthcare median
−1500%−1000%−500%0%500%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearCelularityHealthcare median
FY25−345.4%−30.6%
FY24−106.8%−47%
FY23−862%−58%
FY2279%−80.4%
FY21−469.3%−71.9%
FY20−1458.4%−62.2%
FY19-−46.3%
FY18-−49.6%